Has Infliximab Influenced the Course and Prognosis of Acute Severe Ulcerative Colitis?

Biologics: Targets and Therapy- New Zealand

doi 10.2147/btt.s179006

Full Text

Abstract

Available in

Categories

Gastroenterology

Date

April 1, 2019

Authors

Giovanni Latella

Giuseppe Frieri

Publisher

Informa UK Limited

Related search

Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Letter: Should We Intensify Infliximab in Acute Severe Ulcerative Colitis?

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Inpatient Management of Acute Severe Ulcerative Colitis

Journal of Hospital Medicine

Internal Medicine

English

Reply to Letter to the Editor: Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis

Clinical Gastroenterology and Hepatology

Gastroenterology

English

Acute Colitis and Ulcerative Colitis

English

Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands

Biologics in Therapy

English

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine

English

Successfully Treated Acute Fulminant Myocarditis Induced by Ulcerative Colitis With Extracorporeal Life Support and Infliximab

Journal of Cardiovascular Ultrasound

English

A Comparison of Short-Term Therapeutic Efficacy Between Infliximab and Tacrolimus for Moderate to Severe Ulcerative Colitis

Romanian Journal of Internal Medicine

English